Patient Guide: TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 39 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04485013
Status: 🟢 Enrolling Now
Condition: Cancer
Phase: PHASE1

Where You Can Participate

This study is available at 39 locations across the country.

Top locations include:
  • • Tucson, Arizona
  • • Los Angeles, California
  • • Newport Beach, California
  • • And 36 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers - Join Clinical Trial NCTNCT04485013

How to Join This Clinical Trial - NCTNCT04485013

Learn how to participate in this PHASE1 trial studying an investigational therapy for Cancer. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Cancer. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Cancer
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1 - Early safety study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT04485013 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 39 locations. Find a study site near you:

Clinical Research Site

Tucson, Arizona 85711 - United States

Status: COMPLETED

Clinical Research Site

Los Angeles, California 90033 - United States

Status: COMPLETED

Clinical Research Site

Newport Beach, California 92663 - United States

Status: COMPLETED

Clinical Research Site

Denver, Colorado 80218 - United States

Status: RECRUITING

Clinical Research Site

New Haven, Connecticut 06511 - United States

Status: RECRUITING

Clinical Research Site

Newark, Delaware 19713 - United States

Status: COMPLETED

Clinical Research Site

Washington, District of Columbia 20016 - United States

Status: COMPLETED

Clinical Research Site

Daytona Beach, Florida 32117 - United States

Status: RECRUITING

Clinical Research Site

Fleming Island, Florida 32003 - United States

Status: COMPLETED

Clinical Research Site

Ocala, Florida 34474 - United States

Status: RECRUITING

And 29 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1 clinical trial for Cancer:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships